Topical Agents

Clinical Research Poster

Treatment of Burns with Concentrated Surfactant Technology

10/18/2018

BACKGROUND: Since the presence of necrosis increases the chances of infection and delays healing, most deeper burns are treated with excision, followed by, depending on the depth, autografting or use of a dressing. Debridement is painful and...

BACKGROUND: Since the presence...

10/18/2018

Wounds

Educational Report

Topical Use of Concentrated Surfactant Technology for Removal of Nonviable Tissue and Wound Bed Preparation

10/12/2018

BACKGROUND: Wound bed preparation by removal of various barriers to wound healing, such as nonviable tissue and associated microbiome, is a fundamental principle of wound bed preparation. Timely removal of debris is essential for the...

BACKGROUND: Wound bed...

10/12/2018

Wounds

Clinical Research Poster

Treatment of Pediatric Burns with Concentrated Surfactant Gel Technology (CST) with or Without an Antimicrobial Agent

10/11/2018

OBJECTIVE: A concentrated surfactant gel technology (CST) gel was designed to aid in maintaining moist wound healing and to soften debris, assisting in surfactant driven autolytic debridement. A clinical study was conducted to look at its...

OBJECTIVE: A concentrated...

10/11/2018

Wounds

Educational Report

Economic Model for Cost Containment: Evaluating the Utilization of a Touch-Free Zinc Oxide in an Acute Care Hospital

10/11/2018

BACKGROUND: Incontinence-associated dermatitis (IAD) is a major concern with hospitalized patients and puts them at higher risk for skin breakdown and ulceration. Zinc oxide has been proven to prevent and treat IAD. Hospitals are constantly...

BACKGROUND:...

10/11/2018

Wounds

Clinical Research Poster

Comparing a High-concentration Topical Surfactant With and Without a Topical Antimicrobial in the Management of Burns

10/10/2018

OBJECTIVE: A surface-acting agent based on concentrated surfactant technology (CST), in certain patients in combination with a topical antimicrobial agent, was studied for both debriding properties and wound healing-related aspects in a trial...

OBJECTIVE: A surface-acting...

10/10/2018

Wounds

Case Series

Management of Aplasia Cutis Congenita in Neonates: The Role of Topical Leptospermum Honey

10/10/2018

BACKGROUND: Aplasia cutis congenita (ACC) is an uncommon, heterogeneous group of disorders characterized by focal or widespread absence of skin from certain parts of the body. Complications of ACC include infections, meningitis, bleeding,...

BACKGROUND: Aplasia cutis...

10/10/2018

Wounds

Original Research

Durability of an Advanced Skin Protectant Compared With Other Commercially Available Products in Healthy Human Volunteers

09/01/2018

Mary Mathisen

Gary Grove

Tim Houser

Stéphanie F. Bernatchez

09/01/2018

Wounds

Case Series

Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series

02/28/2018

Dimitrios Lintzeris

Karen Vernon

Heather Percise

Andy Strickland

Kari Yarrow

Amber White

Mary Gurganus

Susan Sherrod

Kathleen Vergin

Laura Johnson

In order to control biofilm formation, sequester proteolytic enzymes, and provide a biocompatible scaffold to support healing, the investigators utilize a purified collagen matrix containing polyhexamethylene biguanide (PCMP) in a case series...

In order to control biofilm...

02/28/2018

Wounds

Original Research

Comprehensive In Situ Killing of Six Common Wound Pathogens With Manuka Honey Dressings Using a Modified AATCC-TM100

06/29/2017

Denis Watson

Stephen Bergquist

Julie Nicholson

David H. Norrie

06/29/2017

Wounds